Aiml Innovations Stock Today
| AIMLF Stock | USD 0.05 0.01 18.30% |
Performance7 of 100
| Odds Of DistressLess than 18
|
AI/ML Innovations is trading at 0.053 as of the 27th of November 2024. This is a 18.30 percent increase since the beginning of the trading day. The stock's lowest day price was 0.0459. AI/ML Innovations has less than a 18 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for AIML Innovations are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of September 2023 and ending today, the 27th of November 2024. Click here to learn more.
AIML Innovations Inc. operates in the digital healthcare business using artificial intelligence and machine learning . AIML Innovations Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. AiMl Innovations is traded on OTC Exchange in the United States. The company has 36.69 M outstanding shares. More on AIML Innovations
Moving together with AI/ML OTC Stock
Moving against AI/ML OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AI/ML OTC Stock Highlights
| Business Concentration | Health Information Services, Healthcare (View all Sectors) |
AIML Innovations [AIMLF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AI/ML Innovations's market, we take the total number of its shares issued and multiply it by AI/ML Innovations's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AI/ML Innovations classifies itself under Healthcare sector and is part of Health Information Services industry. The entity has 36.69 M outstanding shares.
AIML Innovations has accumulated about 294.31 K in cash with (3.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check AI/ML Innovations Probability Of Bankruptcy
Ownership AllocationAI/ML Innovations holds a total of 36.69 Million outstanding shares. AIML Innovations shows 12.35 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check AI/ML Ownership Details
AI/ML Innovations Risk Profiles
| Mean Deviation | 9.38 | |||
| Semi Deviation | 12.68 | |||
| Standard Deviation | 14.08 | |||
| Variance | 198.36 |
AI/ML Stock Against Markets
Picking the right benchmark for AI/ML Innovations otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AI/ML Innovations otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AI/ML Innovations is critical whether you are bullish or bearish towards AIML Innovations at a given time. Please also check how AI/ML Innovations' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in AI/ML Innovations without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
AI/ML Innovations Corporate Management
Elected by the shareholders, the AI/ML Innovations' board of directors comprises two types of representatives: AI/ML Innovations inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AI/ML. The board's role is to monitor AI/ML Innovations' management team and ensure that shareholders' interests are well served. AI/ML Innovations' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AI/ML Innovations' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bruce Matichuk | CTO Director | Profile | |
| CPA CGA | Chief Officer | Profile | |
| Randy Duguay | CEO Pres | Profile | |
| Tim Daniels | Ex Chairman | Profile |
Other Information on Investing in AI/ML OTC Stock
AI/ML Innovations financial ratios help investors to determine whether AI/ML OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AI/ML with respect to the benefits of owning AI/ML Innovations security.